French Food-Tech Company Edonia Raises €15 Million to Scale Microalgae Protein Production
French food-tech company Edonia has secured €15 million in new financing to accelerate the industrial production of its microalgae-based protein ingredient, Edo.
The investment, announced on 6 October 2026, brings together SWEN Blue Ocean 2, Asterion Ventures and EIT Food, with additional support from Bpifrance under the France 2030 programme and bank financing.
For Edonia, the funding represents an important step in moving its technology into larger-scale manufacturing and expanding its presence across international food markets.
A Different Approach to Alternative Proteins
Based in Paris, Edonia is developing protein ingredients derived from microalgae, offering food manufacturers an alternative to conventional animal and plant proteins.
Its flagship ingredient, Edo, is produced from spirulina using the company’s proprietary Edonization process, developed in partnership with AgroParisTech.
The technology transforms microalgae into an ingredient designed to offer a practical combination of protein content, texture and flavour.
Unlike many alternative protein businesses focused on replicating conventional meat products, Edonia is positioning its ingredient as a versatile food component suitable for a broader range of applications.
The company is targeting food manufacturers and foodservice operators looking for nutritious ingredients that can be incorporated into existing product development and manufacturing processes.
Investment to Support Industrial Expansion
The new financing will support the development of a dedicated production facility in France, helping Edonia increase manufacturing capacity and meet growing commercial demand.
According to EIT Food, the company has already secured approximately €30 million in pre-orders through around 20 commercial agreements.
Edonia also plans to expand its B2B foodservice activities across Europe, Japan and the United States.
The business has previously supplied customers including international catering group Newrest, demonstrating early commercial interest in its microalgae-based products.
The investment follows several years of technical and commercial development, including the establishment of pilot production capabilities and the creation of a supply chain to support customer orders.
From Scientific Innovation to Commercial Supply
Edonia’s progress reflects a wider shift taking place across the alternative protein industry.
While scientific innovation remains central to the development of new protein sources, investors and customers are increasingly looking for evidence that emerging technologies can operate at meaningful production volumes.
The challenge is no longer simply demonstrating that an innovative ingredient can be produced. Businesses must also show that it can be manufactured consistently, supplied reliably and incorporated into commercially viable food products.
Edonia’s latest investment provides additional resources to address those challenges.
As the European alternative protein sector continues to develop, businesses capable of combining differentiated technology with clear commercial demand are likely to attract continued attention from investors and food manufacturers.
Source: EIT Food, 6 October 2026. (https://gfieurope.org/blog/investment-in-europes-alternative-protein-companies-grows-but-sector-can-no-longer-rely-on-venture-capital-alone/)
